Angiopoietin-1 reduces iopromide-induced endothelial cell apoptosis through activation of phosphatidylinositol 3′-kinase/P70 S6 kinase

International Journal of Tissue Reactions

Volumn 27, Issue 3, 2005, Pages 115-124

  Moon, S O ^a   Kim, W ^a   Kim, D H ^a   Sung, M J ^a   Lee, S ^a   Kang, K P ^a   Yi, A S ^a   Jang, K Y ^a   Lee, S Y ^a   Park, S K ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOPOIETIN 1; APOPTOSIS INHIBITOR; CONTRAST MEDIUM; IOPROMIDE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; S6 KINASE; WORTMANNIN;

APOPTOSIS; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANALYSIS OF VARIANCE; ANGIOPOIETIN-1; ANIMALS; APOPTOSIS; CATTLE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; IOHEXOL; MANNITOL; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TIME FACTORS; UMBILICAL VEINS;

MAMMALIA;

EID: 28444449871     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Davidson C.J., Hlatky M., Morris K.G., et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann. Intern. Med., 110(2), 119, 1989.
2. Laerum F. Cytotoxic effects of six angiographic contrast media on human endothelium in culture. Acta. Radiol., 28(1), 99, 1987.
3. Morgan D.M., Bettmann M.A. Effects of X-ray contrast media and radiation on human vascular endothelial cells in vitro. Cardiovasc. Intervent. Radiol., 12(3), 154, 1989.
4. Morcos S.K., Dawson P., Pearson J.D., et al. The haemodynamic effects of iodinated water soluble radiographic contrast media: A review. Eur. J. Radiol., 29(1), 31, 1998.
5. Barstad R.M., Buchmann M.S., Hamers M.J., et al. Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation. Acta. Radiol., 37(6), 954, 1996.
6. Fauser C., Ullisch E.V., Kubler W., Haller C. Differential effects of radiocontrast agents on human umbilical vein endothelial cells: Cytotoxicity and modulators of thrombogenicity. Eur. J. Med. Res., 6(11), 465, 2001.
7. Zhang H., Holt C.M., Malik N., Shepherd L., Morcos S.K. Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br. J. Radiol., 73(874), 1034, 2000.
8. Peer A., Averbukh Z., Berman S., Modai D., Averbukh M., Weissgarten J. Contrast media augmented apoptosis of cultured renal mesangial, tubular epithelial, endothelial, and hepatic cells. Invest. Radiol., 38(3), 177, 2003.
9. Zhang J., Duarte C.G., Ellis S. Contrast medium- and mannitol-induced apoptosis in heart and kidney of SHR rats. Toxicol. Pathol., 27(4), 427, 1999.
10. Laerum F., Holm H.A. Postphlebographic thrombosis: A double-blind study with methylglucamine metrizoate and metrizamide. Radiology, 140(3), 651, 1981.
11. Nyman U., Almen T. Effects of contrast media on aortic endothelium. Experiments in the rat with non-ionic monomeric and monoacidic dimeric contrast media. Acts. Radiol. Suppl., 362, 65, 1980.
12. Thiesen B., Mutzel W. Effects of angiographic contrast media on venous endothelium of rabbits. Invest. Radiol., 25(2), 121, 1990.
13. Laerum F., Borsum T., Reisvaag A. Human endothelial cell culture as an evaluation system for the toxicity of intravascular contrast media. Invest. Radiol., 18(2), 199, 1983.
14. Araki S., Simada Y., Kaji K., Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem. Biophys. Res. Commun., 172(3), 1081, 1990.
15. Gerber H.P., McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem., 273(46), 30336, 1998.
16. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature., 407(6801), 242, 2000.
17. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ. Res., 86(1), 24, 2000.
18. Huang S., Bjornsti M.A., Houghton P.J. Rapamycins: Mechanism of action and cellular resistance. Cancer Biol. Ther., 2(3), 222, 2003.
19. Scott P.H., Brunn G.J., Kohn A.D., Roth R.A., Lawrence J.C. Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. U.S.A., 95(13), 7772, 1998.
20. Nave B.T., Ouwens M., Withers D.J., Alessi D.R., Shepherd P.R. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J., 344(pt 2), 427, 1999.
21. Park I.H., Bachmann R., Shirazi H., Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J. Biol. Chem., 277(35), 31423, 2002.
22. Dennis P.B., Pullen N., Kozma S.C., Thomas G. The principal rapamycin-sensitive p70 (s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol. Cell Biol., 16(9), 6242, 1996.
23. Burnett P.E., Barrow R.K., Cohen N.A., Snyder S.H., Sabatini D.M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U.S.A., 95(4), 1432, 1998.
24. Kim W., Moon S.O., Sung M.J., et al. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB. J., 17(13), 1937, 2003.
25. Krause W., Schuhmann-Giampieri G., Staks T., Kaufmann J. Dose proportionality of iopromide pharmacokinetics and tolerability after i.v. injection in healthy volunteers. Eur. J. Clin. Pharmacol., 46(4), 339, 1994.
26. Kim W., Moon S.O., Sung M.J., et al. Protective effect of adrenomedullin in mannitol-induced apoptosis. Apoptosis, 7(6), 527, 2002.
27. Shichiri M., Kato H., Marumo F., Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension, 30(5), 1198. 1997.
28. Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the anti-apoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem., 273(21), 13313, 1998.
29. Kwak H.J., So J.N., Lee S.J., Kim I., Koh G.Y. Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS. Lett., 448(2), 249, 1999.
30. Kwak H.J., Lee S.J., Lee Y.H., et al. Ahgiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation, 101(19), 2317, 2000.
31. Asif A., Garces G., Preston R.A., Roth D. Current trials of interventions to prevent radiocontrast-induced nephropathy. Am. J. Ther., 12(2), 127, 2005.
32. Lin J., Bonventre J.V. Prevention of radiocontrast nephropathy. Curr. Opin. Nephrol. Hypertens., 14(2), 105, 2005.
33. Kshirsagar A.V, Poole C., Mottl A., et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J. Am. Soc. Nephrol., 15(3), 761, 2004.
34. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med., 343(3), 180, 2000.